Pfizer & BioNTech say final analysis shows coronavirus vaccine is 95% effective with no safety concerns

Pfizer is one step closer to a COVID-19 vaccine. The pharmaceutical company has announced that a final analysis of their Phase 3 trial found its vaccine candidate to be 95% effective.